20 participants
Toripalimab Combine With Rituximab for Treatment of Relapsed Refractory CD20 Positive Diffuse Large B-cell Lymphoma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2020-06-16
- Start Date:
- 2020-06-15
- Completion:
- 2022-12-31
Conditions
- Diffuse Large B-cell Lymphoma
- Rituximab
- Toripalimab
Interventions
- DRUG
No Results Yet